This means Medicare Advantage plans can increase their rating when patients complete the Cologuard test. Those plans will receive quality credit for tests performed from 2014 and onward.

“The incentives provided to insurers through the Star Ratings program also should help broaden adoption of Cologuard over time, as we work to make our test a standard of care for colon cancer screening,” said Kevin Conroy, chairman and CEO of Exact Sciences.

See more: http://investor.exactsciences.com/investor-relations/press-releases/press-release-details/2017/CMS-includes-Cologuard-in-updated-Medicare-Advantage-Star-Ratings/default.aspx